Clinical Impact, Costs, and Cost-effectiveness of Expanded Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Massachusetts

We projected the clinical and economic impact of alternative testing strategies on coronavirus disease 2019 (COVID-19) incidence and mortality in Massachusetts using a microsimulation model.

I tiakina i:
Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua: Anne M. Neilan, Elena Losina, Audrey C. Bangs, Clare Flanagan, Christopher Panella, G Ege Eskibozkurt, Amir M. Mohareb, Emily P. Hyle, Justine A. Scott, Milton C. Weinstein, Mark J. Siedner, Krishna P. Reddy, Guy Harling, Kenneth A. Freedberg, Fatma M. Shebl, Pooyan Kazemian, Andrea Ciaranello
Hōputu: Artigo
Reo:Ingarihi
I whakaputaina: 2020
Urunga tuihono:https://doi.org/10.1093/cid/ciaa1418
https://academic.oup.com/cid/article-pdf/73/9/e2908/41060511/ciaa1418.pdf
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!